Innovage Holding 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Innovage Holding in the first quarter 2026?
Innovage Holding Corp achieved a return on average equity (ROE) of 4.52 % in its first quarter 2026 a new company high.

ROE has advanced compared to -0.28% in the fourth quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 55 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2026 from 1629 to 2585.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) I. Quarter	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter
Y / Y Equity Change	3.25 %	0.36 %	-5.22 %	1.88 %	-
Y / Y Net Income Change	154.96 %	-	-	-	-
Net Income (TTM) in Millions	11	-1	-15	3	-22
Return On Equity (TTM)	4.52 %	-0.28 %	-6.31 %	1.34 %	-8.88 %
INNV's Total Ranking	# 2585	# 1629	# 143	# 2299	#
Equity (TTM) in Millions	258	239	233	261	250
Seq. Equity Change	8.04 %	2.57 %	-10.87 %	4.54 %	5.02 %
Seq. Net Income Change	99.87 %	-	-	53.93 %	-

Back to INNV Management Effectiveness >> INNV's 5 Years Annual ROE >> Compare INNV ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 56
Sector	# 168
Overall	# 2585

Return On Equity Statistics
High	Average	Low
4.52 %	-483.99 %	-3731.91 %
(Sep 30 2026)		(Sep 30 2014)

INNV Annual Return On Equity	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Equity in Millions	239	238	278	302	338
Y / Y Equity Change	0.36 %	-14.3 %	-8.1 %	-10.75 %	-5.45 %
Net Income in Millions	-1	-35	-23	-44	-8
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-0.29 %	-14.86 %	-8.36 %	-14.42 %	-2.35 %

Back to INNV Management Effectiveness >> INNV's 5 Years Annual ROE >> Compare INNV ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
INNV's' Return on Equity at Yahoo Finance
INNV's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for INNV's Competitors
Subscribers only: Roe for Innovage Holding 's Suppliers
Subscribers only: Return On Equity for INNV's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Abbott Laboratories	9.00 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %
Integra Lifesciences Holdings Corp	1.24 %

Date modified: 2026-11-06T13:05:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.